Phase 4Not yet recruiting

A study on stopping versus continuing beta-blockers in patients with hypertrophic cardiomyopathy treated with mavacamten

Sponsor

Ziekenhuis Oost Limburg (Academic or other)

Enrollment

90 planned

Conditions

Obstructive Hypertrophic Cardiomyopathy.; Hypertrophic cardiomyopathy; HOCM Hypertrophic obstructive cardiomyopathy; Hypertrophic obstructive cardiomyopathy

Ages

adults, older adults

Registry

CTIS2026-526612-36-00

Full record on the EU Clinical Trials Information System